Pictet Asset Management (UK)’s 10x Genomics TXG Stock Holding History

Pictet Asset Management (UK)’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$29.3M	Sell	149,724 -3,034	-2%	-$549K	0.03%	445
2021 Q1	$27.6M	Buy	152,758 +7,025	+5%	+$1.21M	0.03%	440
2020 Q4	$20.6M	Sell	145,733 -2,941	-2%	-$427K	0.03%	475
2020 Q3	$18.5M	Buy	148,674 +14,334	+11%	+$1.5M	0.03%	441
2020 Q2	$12M	Hold	134,340	–	–	0.02%	496
2020 Q1	$8.37M	Sell	134,340 -28,285	-17%	-$2.21M	0.02%	514
2019 Q4	$12.4M	Buy	162,625 +77,625	+91%	+$4.67M	0.02%	534
2019 Q3	$4.28M	Buy	+85,000	New	+$4.7M	0.01%	736

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Pictet Asset Management (UK)'s TXG Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its 10x Genomics (TXG) stake by 2% in Q2 2021, selling an estimated $549K and leaving 149,724 shares worth $29.3M. The position accounts for 0.03% of the portfolio, ranked #445.

Pictet Asset Management (UK) first reported a position in TXG in Q3 2019 and has held it in 8 quarters since. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

Pictet Asset Management (UK) held 149,724 shares of 10x Genomics worth $29.3M as of Q2 2021.
Pictet Asset Management (UK) sold 3,034 10x Genomics shares in Q2 2021, an estimated $549K.
10x Genomics made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #445 holding.
Pictet Asset Management (UK) first reported a position in 10x Genomics in Q3 2019 and has held it in 8 quarters since.
340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.